Youtube
MEDICAMEQ

Medicamen Biotech Ltd.

₹650.00

Score

24

Technically Bearish

Medicamen Biotech Price Change Analysis

Medicamen Biotech Key Statistics
  • P/E Ratio

    64.6

  • PEG Ratio

    1.1

  • Market Cap Cr

    794.1

  • Price to Book Ratio

    115.8

  • EPS

    10.2

  • Dividend

    10 ()

  • Relative Strength Index

    43.78

  • Money Flow Index

    60.58

  • MACD Signal

    -9.98

  • Average True Range

    46.18

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Medicamen Biotech Synopsis

NSE-Medical-Generic Drugs

Medicamen Biotec is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 110.15 Cr. and Equity Capital is Rs. 12.22 Cr. for the Year ended 31/03/2021. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.
  • Market Cap

    785.92

  • Sales

    113.03

  • Shares in Float

    0.68

  • No of Funds

    3

  • Yield

    0.15

  • Book Value

    6

  • U/D Vol Ratio

    1.2

  • LTDebt/Equity

    5

  • Alpha

    0.08

  • Beta

    0.73

Medicamen Biotech Ownership
Medicamen Biotech Management

Medicamen Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Medicamen Biotech Financials

Medicamen Biotech Technicals

EMA & SMA

CURRENT PRICE

EMA

Medicamen Biotech Resistance and Support

Medicamen Biotech Delivery and Volume

Medicamen Biotech Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Medicamen Biotech share price is

Open Demat Account